Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013
- 188 Downloads
The incidence and the trend of gynaecological cancers have been suggested to vary by ethnicity and geographical regions. Whether the incidence and type of gynaecological cancers in China is different have not been fully investigated. In this study, we reported the trend of gynaecological cancers in China. Data on 13,518 women with gynaecological cancers were collected from the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Data included age at diagnosis and the annual number of women with diagnosed endometrial, ovarian, cervical cancer and other gynaecological cancers. The number of women with diagnosed gynaecological cancers increased by almost sixfold in 2013 compared to that in 2003. It was largely due to the increase of women with newly diagnosed cervical cancer. The percentage of women with endometrial and ovarian cancer within total gynaecological cancers was decreased, whilst the percentage of cervical cancer significantly increased between 2003 and 2013. The mean age of women with endometrial or ovarian cancer at diagnosis was 53 or 48 years, respectively, which was no difference over 11 years. However, the mean age of women with cervical cancer at diagnosis was significantly delayed from 42 years in 2003 to 46 years since 2011. This was also confirmed by the age-specific distribution of gynaecological cancers over 11 years. Our study found that the age onset of endometrial and ovarian cancer has not changed over 11 years. But the age onset of cervical cancer is delayed since 2011 in China.
KeywordsGynaecological cancer Endometrial cancer Ovarian cancer Cervical cancer Age at diagnosis China
This study was supported by Shanghai Hospitals Association Foundation (grant number 2014052 to Xuelian Li). We would like to thank Dr. Greg Gamble from the University of Auckland for statistical analysis help.
Conflict of interest
- 1.Standards of service provision for gynaecological cancer patients in New Zealand - Provisional., M.o. Health, Editor. National Gynaecological Cancer Tumour Standards Working Group: Wellington; 2013.Google Scholar
- 2.Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, et al. National Endometrial Cancer Study, age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol. 2012;176(4):269–78.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Howlader N, NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. 2014.Google Scholar
- 10.Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA. Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst Rev. 2014;5:CD010681.Google Scholar
- 14.Gynaecological cancers in Australia: an overview: Australian Institute of Health and Welfare & Cancer Australia. 2012.Google Scholar
- 16.Lentz GM, L.R., Gershenson DM, Katz VL. Comprehensive gynecology 6th ed. Neoplastic diseases of the uterus: Mosby. 2013Google Scholar
- 20.Ries LAG, YJ, Keel GE, Eisner MP, Lin YD. Horner M-J SEER Survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. National Cancer Institute. Chapter 16: Cancers of the Ovary. 2007.Google Scholar